The Global Market for Intravenous Immunoglobulin (IVIg) is Projected to Reach US$15.9 Billion by 2024
Rising Incidence of Immune Disorders Drive the Intravenous Immunoglobulin (IVIg) Market, According to a New Report by Global Industry Analysts, Inc. GIA launches comprehensive analysis of industry segments, trends, growth drivers, market size, share and demand forecasts on the global Intravenous Immunoglobulin (IVIg) market. The global market for Intravenous Immunoglobulin (IVIg) is projected to reach US$15.9 billion by 2024 , driven by aging population, increasing incidence of autoimmune diseases such as lupus, growing awareness and rising adoption in emerging markets. Immunoglobulins or antibodies are naturally occurring human blood constituents that when extracted and concentrated find use in the treatment of various diseases related to immune deficiency. Intravenous Immunoglobulin (IVIg) contains pooled immunoglobulin/antibody G that is administered intravenously for the treatment of various immune deficiencies. Currently, IVIg is the most important blood plasma protein t...